Comparison of efficacy of turmeric and commercial curcumin in immunological functions and gene regulation

International Journal of Pharmacology

Volumn 5, Issue 6, 2009, Pages 333-345

  Chakravarty, A K ^a   Chatterjce, S N ^b   Yasmin, H ^a   Mazumder, T ^a  

^a UNIVERSITY OF NORTH BENGAL   (India)

^b Ministry of Textiles   (India)

Author keywords

Curcumin; Delayed type hypersensitive reaction; Ethanolic extract of turmeric rhizome; Gene expression; Reactive oxygen species

Indexed keywords

CURCUMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TURMERIC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; DRUG STRUCTURE; EDEMA; GENE EXPRESSION; IMMUNOSTIMULATION; LEUKOCYTE COUNT; LIPID PEROXIDATION; MOUSE; NONHUMAN; REGULATORY MECHANISM; SWELLING; T LYMPHOCYTE; UPREGULATION;

EID: 73449109844     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2009.333.345     Document Type: Article

References (81)

1. Abe, Y., Y. Hashimoto and T. Horic, 1999. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol. Res., 39: 41-47.
2. Aggarwal, B.B., A. Kumar and A.C. Bharti, 2003. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res., 23: 363-398.
3. Aggarwal, S., Y. Takada, S. Singh, J.N. Myers and B.B. Aggarwal, 2004. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor kappa B signaling. Int. J. Cancer, 111: 679-692.
4. Aggarwal, S., H. Ichikawa, Y. Takada, S.K. Sandur, S. Shishodia and B.B. Aggarwal, 2006. Curcumin (Diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkBá kinase and Akt activation. Mol. Pharmacol., 69: 195-206.
5. Alin, A., 2006. Testing non-additivity (interaction) in two-way anova table with no replication. Stat. Methods Med. Res., 15: 63-85.
6. Ammon, H.P. and M.A. Wahl, 1991. Pharmacology of Curcuma longa. Planta Med., 57: 1-7.
7. Anto, R.J., A. Mukhopadhyay, K. Denning and B.B. Aggarwal, 2002. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23: 143-150.
8. Arora, R.B., N. Basu, V. Kapoor and A.P. Jain, 1971. Anti-inflammatory studies on Curcuma longa (turmeric). Indian J. Med. Res., 59: 1289-1295.
9. Balkwill, F. and A. Mantovani, 2001. Inflammation and cancer: Back to virchow? Lancet, 357: 539-545.
10. Bandhopadhy, U., D. Das and K.R. Banerjee, 1999. Reactive oxygen species: Oxidative damage and pathogenesis. Curr. Sci., 77: 658-665.
11. Berger, C.L. and R.L. Edelson, 1979. Comparison of lymphocyte function after isolation by ficoll hypaque flotation or elutriation. J. Invest. Dermatol., 73: 231-235.
12. Bharti, A.C., N. Donato and B.B. Aggarwal, 2003a. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol., 171: 3863-3871.
13. Bharti, A.C., N. Donato, S. Singh and B.B. Aggarwal, 2003b. Curcumin (diferuloylmethane) down-regalates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 101: 1053-1062.
14. Bosca, A.R., M.A. Carrion-Gutierrez, A. Soler, C. Puerta and A. Diez et al., 1997. Effects of the antioxidant turmeric on lipoprotein peroxides: Implications for the prevention of atherosclerosis. Age, 20: 165-168.
15. + T cells using RosetteSep™ and MACS™ for studies of DNA turnover by deuterium labeling. J. Immunol. Methods, 286: 97-109.
16. Chakravarty, A.K. and W.R. Clark, 1977. Lectin driven maturation of cytotoxic effector cells: The nature of effector memory. J. Exp. Med., 146: 230-240.
17. Chakravarty, A.K., H. Yasmin and S.K. Das, 2003. Two way efficacy of alcoholic turmeric extract: Stimulatory for murine lymphocytes and inhibitory for ascitic fibrosarcoma. Pharm. Biol., 42: 217-224.
18. Chakravarty, A.K. and H. Yasmin. 2005. Alcoholic turmeric extract simultaneously activating murine lymphocytes and inducing apoptosis of Ehrlich's Ascitic Carcinoma cells. Int. Immunopharmacol., 5: 1574-1581.
19. Chakravarty, A.K. and H. Yasmin, 2008. Free radical scavenging and nitric oxide synthase activation in murine lymphocytes and Ehrlich ascitic carcinoma cells treated with ethanolic extract of turmeric. Proc. Natl. Acad. Sci. India, 78: 37-44.
20. Chan, M. M., 1995. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol., 49: 1551-1556.
21. Chandra, D. and S.S. Gupta, 1972. Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi). Indian J. Med. Res., 60: 138-142.
22. Chaudhuri, T.K. and A.K. Chakravarty, 1983. Goat serum as a substitute for fetal calf serum in in vitro culture of murine lymphocytes. Indian J. Exp. Biol., 21: 494-496.
23. Chen, H.W., S.L. Yu, J.J. Chen, H.N. Li and Y.C. Lin et al., 2004. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol. Pharmacol., 65: 99-110.
24. Chen, A., J. Xu and A.C. Johnson, 2006. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of transcription factor Egr-1. Oncogene, 25: 278-287.
25. Cheshire, J.L. and A.S. Baldwin Jr., 1997. Synergistic activation of NF-B by tumor necrosis factor alpha and gamma interferon via enhanced IkBα degradation and de novo IkBβ degradation. Mol. Cell Biol., 17: 6746-6754.
26. Choudhuri, T., S. Pal, M.L. Aggarwal, T. Das and G. Sa, 2002. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett., 512: 334-340.
27. Choudhuri, T., S. Pal. T. Das and G. Sa, 2005. Curcumin selectively induces apoptosis in deregulated cyclin D1 expressed cells at G2 phase of cell cycle in p53-dependent manner. J. Biol. Chem., 280: 20059-20068.
28. Das, S.K. and A.K. Chakravarty, 1997. Characterization of primed lymphocytes on the basis of sensitivity of chromatin to Dnase I. Indian J. Exp. Biol., 54: 1156-1160.
29. Daube, F.V., 1870. Uber curcumin, den farbstoff der curcumawurzel. Berichte Deutschen Chemischen Gesellschaft, 3: 609-613.
30. Dohare, P., P. Garg, U. Sharma, N.R. Jagannathan and M. Ray, 2008. Neuroprotective efficacy and therapeutic window of curcuma oil: In rat embolic stroke model. BMC Complementary Alternative Med., 8: 55-74.
31. Fruehauf, J.P. and F.L. Meyskens Jr., 2007. Reactive oxygen species: A breath of life or death?. Clin Cancer Res., 13: 789-794.
32. Gao, X., J. Kuo, H. Jiang, D. Deeb and Y. Liu et al., 2004. Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity and cytokine production in vitro. Biochem. Pharmacol., 68: 51-61.
33. Grant, K.L., 2000. Alternative therapies: Turmeric. Am. J. Health Syst. Pharm., 57: 1121-1122.
34. Gulucubuk, A., K. Altunatmaz, K. Sonmez, D. Haktanir-Yatkin and H. Uzun et al., 2006. Effects of curcumin on tumor necrosis factor-α and interleukin-6 in the late phase-of experimental acute pancreatitis. J. Vet. Med. Ser. A, 53: 49-54.
35. Halliwell, B., J.M.C. Gutteridge and O.I. Aruoma. 1987. The deoxyribose method, a simple test tube assay for determination of rate constants for reactions of hydroxyl radicals. Anal. Biochem., 165: 215-219.
36. Henkart, P.A., 1989. Mechanisms of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol., 3: 31-58.
37. Iizima, M. and S.I. Katz, 1983. Specific immunologic tolerance to dinitrofluorobenzene following topical application of dinitrothyocyanobenzene: Mulation by suppressor T-cells. J. Invest. Dermatol., 81: 325-330.
38. Jia, L., C. Bonaventua, J. Bonaventura and J.S. Stamler, 1996. S-nitrosohemoglobulin: A dynamic activity of blood involved in vascular control. Nature, 380: 221-226.
39. Jobin, C., C.A. Bradhan, M.P. Russo, B. Juma, A.S. Narula and D.A. Brenner, 1999. Curcumin blocks cytokine mediated NF-kB activation and proinflammatory gene expression by inhibiting factor IkB activity. J. Immunol., 163: 3474-3483.
40. Julius, M., E. Simpson and A.L. Herzenberg, 1973. A rapid method tor isolation of functional thymus derived murine lymphocytes. Eur. J. Immuno., 3: 645-649.
41. Kagi, D., B. Ledermann, K. Burki, P. Seiler and B, Odermatt et al., 1994, Cytotoxicity mediated by T cells and nalural killer cells is greatly impaired in perforin-deficient mice. Nature. 369: 31-37.
42. Koide, T., M. Nose, Y. Ogihara, Y. Yabu and N. Ohta, 2002. Leishmanicidal effect of curcumin in vitro. Biol. Pharm. Bull., 25: 131-133.
43. Kuttan, R., P. Bhanumathy, K. Nirmala and M.C. George, 1985. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett., 29: 197-202.
44. Leela, N.K., A. Tava, P.M. Shafi, S.P. John and B. Chempakam, 2002. Chemical composition of essential oils of turmeric (Curcuma longa L.). Acta Pharm., 52: 137-141.
45. Mace, F.K., J. Ehrke, K. Hori and D.L. Maccubbin, 1988. Role of tumor necrosis factor in macrophage activation and tumoricidal activity. Cancer Res., 48: 5427-5432.
46. Martin, J.P., M. Dailey and E. Sugarman, 1987. Negative and positive assays of superoxide dismutase based on hematoxilin autoxidation. Arch. Biochem. Biophys., 255: 329-336.
47. 4+ T cells from mouse lymph nodes using miltenyi MACS purification. J. Vis. Exp., 2007: 409-409.
48. Miguel, J., A. Bernd, J.M. Sempere, J. Diaz-Alperi and A. Ramirez, 2002. The curcuma anti-oxidants: Pharmacological effects and prospects for future clinical use. A review. Arch. Gerontol. Geriatr., 34: 37-46.
49. Miller, D.M. and S.D. Aust, 1989. Studies of ascorbate dependent, iron-catalyzed lipid peroxidation. Arch. Biochem. Biophys., 271: 113-119.
50. Mukundan, M.A., M.C. Chacko, V.V. Annapurna and K. Krishnaswammy, 1993. Effect to turmeric and curcumin on BP-DNA adducts. Carcinogenesis, 14: 493-496,
51. Negi, P.S., G.K. Jayaprakash, L. Jagan-Mohan-Rao and K.K. Sakaria, 1999. Anti-bacterial activity of turmeric oil: A byproduct from curcumin manufacture. J. Agric. Food Chem., 47: 4297-4300.
52. Niedbala, W., X.Q, Wei, D. Piedrafita, D. Xu and F.Y. Liew, 1999. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur. J. Immunol., 29: 2498-2505.
53. Niedbala, W., X.Q. Wei. C. Campbell, D. Thomson, M. Komai-Koma and F.Y. Liew, 2002. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up regulating IL-12 receptor 2 expression via cGMP. Proc. Natl. Acad. Sci. USA., 99: 16186-16191.
54. Nigam, M.C. and A. Ahmad, 1990. Curcuma longa terpenoid composition of its essential oil. Indian Perfumer, 35: 255-257.
55. Rafatullah, S., M. Tariq, M.A. Al-Yahya, J.S. Mossa and A.M. Ageel, 1990. Evaluation of turmeric (Curcuma longa) for gastric and duodenal anti-ulcer activity in rats. J. Ethnopharmacol., 29: 25-34.
56. Raina, V.K., S.K. Srivastava and K.V. Syamsundar, 2005. Rhizome and leaf oil composition of curcuma longa from the lower Himalayan Region of Northern India. J. Essential Oil Res., 17: 556-559.
57. Rappolee, H.A., C.A. Brenner, R. Schultz, D. Mark and Z. Werb, 1988. Developmental expression of PDGF, TGF-alpha and TGF-beta genes in preimplantation mouse embryos. Science, 241: 1823-1825.
58. Rasmussen, H.B., S.B. Christensen, L.P. Kvist and A. Karazmi, 2000. Ësimple and effective separation of the curcumins, the anti-protozoal constituents of Curcuma longa. Planta Med., 66: 396-398
59. Rossi, D. and A. Zlotnik, 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol., 18: 217-242.
60. Roughley, P.L. and D.A. Whiting, 1973. Experiments in the biosynthesis of curcumin. J. Chem. Soc. Perkin Trans., 20: 2379-2382.
61. Samy, R.P., P.N. Pushparaj and P. Gopalakrishnakone, 2008. A compilation of bioactive compounds from ayurveda. Bioinformation, 3: 100-110.
62. Satoskar, R.R., S.J. Shah and S.G. Shenoy, 1986. Evaluation of the anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol., 24: 651-654.
63. Selvam, R., L., Subramanian, R. Gayathri and N. Angayarkanni, 1995. The anti-oxidant activity of turmeric (Curcuma longa). J. Ethnopharmacol., 47: 59-67.
64. Sharma, R.A., H.R. McLelland, K.A. Hill, C.R. Ireson and S.A. Euden et al., 2001. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res., 7: 1894-1900.
65. Siddiqui, A.M., X. Cui, R. Wu, W. Dong, M. Zhou and M. Hu et al., 2006. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit. Care Med., 34: 1874-1884.
66. Singh, S. and B.B. Aggarwal. 1995. Activation of transcription factor NF-B is suppressed by curcumin (diferuloylmethane). J Biol Chem., 270: 24995-25000.
67. Sirish-Kumar, I.V.M.L.R., B.N. Paul, R. Asthama, A.K. Saxena, S. Mehrotra and G. Rajan, 2003. Swertia chirayita mediated modulation of interleukin-1, interleukin-6, interleukin-10, interferon-and tumor necrosis factorá in arthritic mice. Immunopharmacol. Immunotoxicol., 25: 573-583.
68. Smitha, S., B.L. Dhananjaya, R. Dinesha and L. Sinivas, 2009. Purification and characterization of a ∼34 kDa protein (α-turmerin) from turmeric (Curcuma longa) waste grits. Biochimie, 91: 1156-1162.
69. Srimal, R.C., 1997. Turmeric a brief review of medicinal properties. Fitotcrapia, 68: 483-493.
70. Srivastava, K.C., A. Bordia and S.K. Verma, 1995. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot. Essential Fatty Acids, Stanciu, L.A. and R. Djukanovic, 2000. Isolation of T cell subsets by magnetic cell sorting. Methods Mol. Biol., 134: 133-133.
71. Stockinger, B. and M. Veldhoen, 2007, Differentiation and function of Th17 T-cells. Cure. Opin. Immunol., 19: 281-286.
72. Tamul, K.R., J.L. Schimtz, K. Kane and J.D. Folds, 1995. Comparison of the effects of ficoll-hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic Malignancies. Clin. Diagnostic Lab. Immunol., 2: 337-342.
73. Thangapazham, R.L., A. Sharma and R.K. Maheswari, 2006. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J., 8: E443-E449.
74. Thiemermann, C., 2006. The spice of life: Curcumin reduces the mortality associated with Experimental sepsis. Crit. Care Med., 34: 2009-2011.
75. Torisu, H., M. Ono, H. Kiryu, M. Furue and Y. Ohmoto et al., 2000. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNT-α and JL-1β. Int. J. Cancer, 85: 182-188.
76. Tschopp, J. and M. Nabholz, 1990. Perforin mediated target cell lysis by cytolytic T lymphocytes. Annu. Rev. Immunol., 8: 279-302.
77. Voskoboinik, I. and J.A. Trapani, 2006. Addressing the mysteries of perforin function. Immunol. Cell Biol., 84: 66-71.
78. Xinjian, L. and L. Xiaochung, 2005. Effect of curcumin on immune function of mice. J. Huazhong Univ. Sci. Technol. Med. Sci., 25: 137-140.
79. Yamamoto, H., K. Hanada, K. Kawasaki and M. Nishijima, 1997. Inhibitory effect of curcumin on mammalian phospholipase D activity, FEBS Lett., 417: 196-198.
80. Yasmin, H., 2007. Analysis of the effects of Curcuma longa Linn. on lymphocytes and malignant cells in murine model for immunotherapy. Ph.D. Thesis, Univesity of North Bengal, Sliguri, India.
81. Young, J.D., 1989. Killing of target cells by lymphocytes: A mechanistic view. Physiol. Rev., 69: 250-314.